To investigate mechanisms for the regulation of glucose incorporation into triacylgycerols in adipocytes by ceramides, which mediate some actions of tumour necrosis factor-alpha (TNFa). DESIGN: The effects of C 2 -and C 6 -ceramides (N-acetyl-and N-hexanoyl-sphingosines, respectively) on glucose uptake and incorporation into triacylglycerols and pathways of signal tansduction were measured in 3T3-L1 adipocytes. RESUTLS: C 6 -ceramide increased basal 2-deooxyglucose uptake but decreased insulin-stimulated uptake without changing the EC 50 for insulin. Incubating 3T3-L1 adipocytes from 2 to 24 h with C 2 -ceramide progressively increased glucose incorporation into the fatty acid and especially the glycerol moieties of triacylglycerol. These effects were accompanied by increased GLUT1 synthesis resulting from ceramide-induced activation phosphatidylinositol 3-kinase, ribosomal S6 kinase and mitogen-activated protein kinase. C 2 -ceramide also increased p21-activated kinase and protein kinase B activities. However, C 2 -ceramide decreased the insulin-stimulated component of these signalling pathways and also glucose incorporation into triacylglycerol after 2 h. CONCLUSIONS: Cell-permeable ceramides can mimic some effects of TNFa in producing insulin resistance. However, ceramides also mediate long-term effects that enable 3T3 L1 adipocytes to take up glucose and store triacylglycerols in the absence of insulin. These observations help to explain part of the nature and consequence of TNFa-induced insulin resistance and the control of fat accumulation in adipocytes in insulin resistance and obesity.
Introduction
Insulin resistance is associated with android obesity, type 2 diabetes, hypertension and dyslipidaemia. This Metabolic Syndrome represents a major risk factor for premature cardiovascular disease. 1, 2 Insulin resistance also develops in cancer, sepsis, endotoxaemia, trauma, infection and alcoholism and this may be associated with the production of tumour necrosis factor-a (TNFa). 3 This latter cytokine is also produced in the adipose tissue of obese insulin-resistance rodents 4 and human beings. 5, 6 Neutralization of TNFa with antibodies in insulin-resistance rodents increases insulininduced glucose uptake. 4 TNFa, therefore, could be a key mediator of obesity-linked insulin resistance, 2 -4,7,8 but the mechanisms for this are controversial. TNFa was proposed to increase the serine phosphorylation of insulin receptor substrated (IRS-1) and decrease its tyrosine phosphorylation by insulin. 9 This in turn decreases the tyrosine phosphorylation of the insulin receptor 9 and activation of phosphatidylinositol (PI) 3-kinase (3-K). 10, 11 TNFa activates several signalling cascades, which include the stimulation of sphingomyelinases and the production of ceramides through the p55 receptor. 12 -14 Ceramides can then stimulate serine/threonine kinases 13 and phosphoprotein phosphatases 12 and they inhibit phospholipase D1 and D2. 15 The involvement of ceramides in mediating the effects of TNFa was demonstrated by using cell-permeable ceramides and sphingomyelinase, which were reported to decrease the tyrosine phosphorylation of IRS-1 17, 18 and activated phosphoprotein phosphatase-1. 19 TNFa could also inhibit insulin signalling in human adipocytes through the p80 TNFa receptor.
In other work, TNFa did not decrease the tyrosine phosphorylation of IRS-1, but rather it decreased the concentrations of IRS-1 and GLUT4 in adipocytes. 21, 22 This effect was not mediated by signalling through ceramides. 22 In fact, ceramides stimulated rather than inhibited PI 3-K activity associated with IRS-1 and the ceramide-induced inhibition of insulin-stimulated glucose probably resulted from decreased insulin-induced transport of vesicles containing GLUT1 and GLUT4 to the cell surface. 22 Our later studies with Rat2 fibroblasts demonstrate that TNFa, sphingomyelinase and C 2 -ceramide rapidly stimulate tyrosine kinases, production of Ras-GTP and its association with activated PI 3-K. 23, 24 Furthermore, incubation of 3T3-L1 adipocytes with TNFa increases the tyrosine phosphorylation of IRS-1 and its binding to PI 3-K. 25 Ceramides also activate Src and PI 3-K in smooth muscle cells. 26 In L6 myocytes, ceramides inhibit insulin-stimulated glucose uptake, but this did not depend upon decreased IRS-1 phosphorylation, or PI 3-K activity. 27 Ceramides appear to inhibit insulin-stimulated glucose uptake downstream of PI 3-K at the level of protein kinase B (PKB). 28 In contrast to these effects on insulin-stimulated glucose uptake, TNFa and ceramides stimulate insulin-independent glucose uptake in the long-term in 3T3-L1 adipocytes through PI 3-K activation. 22, 29, 30 The present work was performed to expand this hypothesis and to understand how ceramide-induced changes in insulin sensitivity modify glucose storage as triacylglycerol (TAG). Ceramides rapidly decreased the insulin-stimulated incorporation of glucose into the fatty acid (FA) and glycerol moieties of triacylglycerol. However, in the longer term (2 -24 h) ceramides progressively increased basal glucose uptake in the absence of insulin and its incorporation into FA and especially glyceride -glycerol. This was accompanied by increased GLUT1 synthesis that depended on the stimulations of ERK, PI 3-K and pp70 S6K . Cell culture Murine 3T3-L1 fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum and then differentiated as described previously. 22, 31 The medium was then changed and the cells were treated with the indicated agents for various times. The final concentrations of C 2 -and C 6 -ceramides were 50 or 100 mM as established previously 22 and they were added to the albumin or serum containing solution in DMSO (final concentration < 0.3%). Albumin binds ceramides but decreases their effective concentration 22 and it also has the benefit of binding FA that are released by the adipocytes. Cells were used within three to nine passages.
Materials and methods

Materials
Lipid synthesis and glucose uptake 3T3-L1 adipocytes were cultured in 35 mm dishes with DMEM containing 10% foetal bovine serum and the agonists or vehicle. At 2 h before the assay, the medium was changed and cells were incubated in DMEM containing 0.5% BSA with agents or vehicle. For the measurement of lipid synthesis, cells were washed with Krebs-Ringer phosphate buffer, and incubated in the same buffer supplemented with [U- 14 C]glucose (0.25 mCi/ml) and agonists in the presence or absence of 20 nM insulin for 2 h. Cells were scraped from the dishes in 1 ml methanol and lipids were extracted by adding 1 ml chloroform and 0.9 ml of 320 mM HCl. TAG was hydrolysed in 2.67 mM NaOH at 78 C for 2 h and the incorporations of 14 C into FA and glyceride -glycerol were determined. 32, 33 Glucose uptake was measured over 10 min by adding 2-[ 3 H]deoxyglucose (0.5 mCi/0.8 ml, 0.1 mM). 22, 29 In the presence of ceramides, > 90% of glucose uptake was inhibited by 20 mM cytochalasin-B.
Cell membrane fractionation and immunoblotting Cells in 100 mm dishes were incubated with test agents as indicated, and stimulated 100 nM insulin for 5 -10 min. Prior to harvesting, cells were rinsed with ice-cold phosphate-buffer saline and scraped in homogenization buffer (10 nM Tris, pH 7.4, 1 mM EDTA, 0.25 M sucrose, 0.5 mM PMSF, 2.5 mg/ml aprotinin, and 1 mg/ml leupeptin). Total and plasma membranes were isolated and resuspended
Ceramides and insulin signalling J Mei et al in homogenization buffer (1 -5 mg/ml protein) for assay 5 0 -nucleotidase activity which was used as the plasma membrane marker. 22, 34 Proteins were separated by SDS -PAGE using 7 or 12% gels 35 , and transferred to nitro-cellulose (Bio-Rad) or Immobilon-P(Millipore) in 25 mM Tris/HCl, pH 7.4, 192 mM glycine and 20% methanol. After transfer, the membrane was blocked in 1% non-fat milk and 1% BSA at 4 C overnight. Results were visualized with anti-rabbit, or anti-mouse IgG antibodies conjugated with horseradish peroxidase and an enhanced chemoluminescence kit. 22 p65PAK, PP70 S6K , and p42 and p44 MAP kinases (ERK) were immunoprecipitated from total cell lysates. p65PAK was resolved by SDS -PAGE and the activity determined by an in-gel assay. 36 For MAP kinase, cells were harvested in lysis buffer A (1% Nonidet p40, 10% glycerol, 50 mM Hepes, 137 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 2mM Na 3 VO 4 , 10 mM Na 4 P 2 O 7 , 100 mM NaF, 5 mg/ml aprotinin, 1 mmol/l PMSF and 1 mg/ml leupeptin). The lysis buffers for PKB were the same as lysis buffer A but with the addition of 1% Triton X-100,5 mM benzamidine and 10 mM dithiothreitol whereas that for pp70 S6K contained 1% Triton X-100, 10 mg/ml antipain and 1 mg/ml leupeptin, 1 mM dithiothreitol and 1 mg/ml pepstatin. The activities of PKB 37, 38 and MAP kinase 39 were measured by phosphorlyation of myelin basic protein, whereas that of pp70 S6K was determined by the phosphorylation of the peptide KKRNRTLTK. 40 Statistical analysis Statistical differences were determined by analysis of variance with appropriate post hoc multiple comparison as indicated. Analysis of the effect of insulin concentration on 2-deoxyglucose uptake ( Figure 1 ) was performed using an ALLFIT program. 41 
Results
Effects of cell-permeable ceramides on glucose uptake and expression of GLUT1 Our previous work demonstrated that C 2 -and C 6 -ceramides decreased insulin-stimulated glucose uptake, but increased basal glucose uptake, in 3T3-L1 adipocytes. 22 The present work determined whether C 6 -ceramide modifies the insulin dose -response curve. 3T3-L1 adipocytes were incubated with 100 mM C 6 -ceramide for 6 h and then exposed to various insulin concentrations for 30 min ( Figure 1A ). C 6 -ceramide increased basal 2-deoxyglucose transport by 1.65 AE 0.12-fold in three independent experiments, but decreased total glucose transport in the presence of 100 and 1000 nM insulin ( Figure 1A ). The insulin-induced component of glucose transport was decreased by ceramide treatment at 10, 100 and 1000 nM insulin ( Figure 1B ). At the physiological concentration of 10 nM insulin, this inhibition was about 50%. There was no change in the calculated EC 50 for insulin (31 and 37 nM, respectively, for control and ceramide-treated cells). This result is compatible with the lack of change in the expression of the insulin receptor, or in its tyrosine phosphorylation in response to insulin stimulation after exposure to ceramides. 22 However, the calculated maximum stimulation of glucose uptake was decreased from 1930 pmol/min per 2Â10 6 cells to 1590 pmol/min per 2Â10 6 cells ( Figure 1 ). These results indicate that the ceramide effects on insulin-stimulate glucose uptake occur on signalling downstream of the activation of the insulin receptor. Figure 1 Effect of C 6 -ceramide on the stimulation of 2-deoxyglucose transport by insulin. Differentiated 3T3-L1 adipocytes were incubated in DMEM supplemented with 10% foetal bovine serum (s), or the medium containing 100 mM C 6 -ceramide () for 4 h. Cells were then incubated in DMEM containing 0.5% BSA (w/v) with or without ceramide for 2 h. After washing twice with Krebs-Ringer phosphate buffer, cells were exposed to 0 -1000 nM insulin for 30 min. Glucose uptake was measured by adding 0.1 mM 2-[ 3 H]deoxyglucose (0.5 mCi/35 mm dish). After incubation for 10 min, the medium was withdrawn and the cells were washed three times with ice-cold Krebs -Ringer phosphate buffer. Glucose transport was calculated from the radioactivity taken up by the cells (A). Insulin-dependent glucose transport was calculated as the difference between glucose uptake in the presence and absence of insulin (B). Results are means AE s.d. (where large enough to be shown) of duplicate determinations from three independent experiments. Significant differences between control and ceramide-treated cells are indicated by *P < 0.05, **P < 0.01 and ***P < 0.001.
Ceramides and insulin signalling J Mei et al
Effects of ceramides on signalling downstream of the insulin receptor We postulated that ceramides increase basal glucose uptake progressively up to 24 h mainly by increasing GLUT1 synthesis and its expression at the plasma membrane. 22 Increases in GLUT1 synthesis in L6 myocytes are mediated by increases in PI 3-K activity that subsequently increase the activity of pp70 S6K . 42, 43 In 3T3-L1 adipocytes simultaneous stimulation of the Ras-Raf-ERK pathway is also needed for optimum stimulation of GLUT1 synthesis. 44 The mechanism for the ceramide-induced increase in GLUT1 synthesis was investigated by incubating 3T3-L1 adipocytes for 12 h with C 2 -ceramide, which produces more marked increases in glucose uptake compared with C 6 -ceramide. 22 Treatment with C 2 -ceramide increased GLUT1 concentration in the cells by 5.04 AE 0.96-fold and the expression on the plasma membrane by 9.23 AE 1.6-fold in three independent experiments (Figure 2 ). These increases were on average 42, 30 and 25% lower when the cells were treated with Ly 294002, rapamycin or PD 98059, respectively. These inhibitors block the activity of PI 3-K and the activation of pp70 S6K and MAP kinase (ERK) respectively. However, GLUT4 concentration were not increased significantly by C 2 -ceramide as expected, 22 nor was GLUT4 expression significantly affected by Ly 294002, rapamycin or PD 98059. However, C 2 -ceramide alone did increase the amount of GLUT4 in the plasma membranes by an average of 70% ( Figure 2 ) as expected from our previous studies. 22 We demonstrated that treating 3T3-L1 adipocytes with C 2 -ceramide for 12 h increased the PI 3-K activity associated with IRS-1 by about 2-fold. 22 The present studies show that treatment for 2 and 12 h with C 2 -ceramide alone increased pp70 S6K activity by 3.7-and 1.7-fold, respectively (Table 1) . Treatment with 100 nM insulin alone for 10 min increased pp70 S6K activity by 2.9-fold. By comparison, in cells treated with C 2 -ceramide, the additional stimulation of pp70 S6K by acute treatment with insulin was much lower. Treatment with C 2 -ceramide for 12 h also increased the activity of p65PAK by about 1.5-fold compared with the 2.1-fold increase in response to acute treatment with 100 nM insulin Figure 2 Effects of Ly294002, rapamaycin and PD98059 on the distribution of glucose transporters in total and plasma membranes. Differentiated 3T3-L1 adipocytes were incubated with 100 mM C 2 -ceramide or C 2 -ceramide plus 20 mM Ly294002, 20 ng/ml rapamycin, or 50 mM PD98059 for 12 h. After incubation, the cells were fractionated into total membrane (TM) and plasma membranes (PM). GLUT1 and GLUT4 were analysed by immunoblotting using 50 mg protein per lane. The results are from a representative experiment that was repeated three times. Table 1 Effect of C 2 -ceramide on the activation of pp70 S6K , p65PAK, PKB and MAP kinase (ERK). Differentiated 3T3-L1 adipocytes were incubated with 100 mM C 2 -ceramide for 2, 12 or 24 h and the cells were then treated in the presence or absence of 100 nM insulin for 5 or 10 min. Cells were lysed and the kinases were precipitated separately in different experiments using appropriate antibodies. Kinases activities were determined with myelin basic protein as substrate for p65PAK, PKB and MAP kinase and the KKRNRTLTK peptide for pp70 S6K . Results are expressed relative to the value of untreated cells and are expressed as means AE s.e.m. for three or five independent experiments. Statistical differences were calculated by analysis of variance followed by a Fisher multiple range test, *P < 0.001, **P < 0.0001, compared with the value for untreated cells. There were no statistically significant differences between results obtained in the presence of C 2 -ceramide vs the corresponding values in the presence of insulin and C 2 Ceramides and insulin signalling J Mei et al (Table 1 ). p65PAK activity in the presence of C 2 -ceramide and insulin was 1.7-fold higher than in non-treated cells. Therefore, there was no significant stimulation by insulin above the ceramide effect. Treatment of the adipocytes with C 2 -ceramide for 2 or 24 h increased PKB activity by 2.0-and 3.1-fold, respectively (Table 1) . However, 100 nM insulin stimulated PKB acutely by about 2.4-fold in control cells. C 2 -ceramides decreased the insulin-dependent stimulation of PKB and after 24 h no significant insulin effect was obtained. The effects of insulin and C 2 -ceramide on ERK activity were determined first by using a gel shift assay. As expected, incubation for 5 min with 100 mM insulin caused a gel shift for ERK. Treatment of the cells for 2 h with C 2 -ceramide did not produce an obvious gel shift, but this was observed after 12 h incubation (Figure 3 ). There appeared to be no significant effect of C 2 -ceramide on the total activation of ERKs in the presence of insulin. Addition of 20 ng/ml rapamycin or 20 mM Ly294002 did not affect the gel shifts that were produced by C 2 -ceramide or insulin at the 12 h point (results not shown). The gel shift results were also verified by determining ERK activity after immunoprecipitation (Table 1) . Insulin (100 nM) stimulated the activity of the ERK after 5 min by 7.9-fold in three independent experiments with control cells. Incubation with 100 mM C 2 -ceramide for 12 h increased the activity of ERK by an average of 2.5-fold. There was no significant difference in the total stimulation of the ERK in the presence of insulin in control vs ceramide treated cells. Therefore, the insulin-dependent component of the stimulation was decreased by ceramide treatment.
Effects of C 2 -ceramide on glucose incorporation into TAGs in the presence and absence of insulin
The major fate of glucose in adipocytes is incorporation into TAG through FA synthesis and incorporation of glycerol phosphate. Treatment of the adipocytes with 20 nM insulin increased [ 14 C]glucose incorporation into the FA of TAG by about 18-fold ( Figure 4A ). Preincubation of the cells for 2 h with 50 mM C 2 -ceramide decreased the insulin-dependent component by about 80% and after 24 h incubation with C 2 -ceramide there was little insulin-dependent FA synthesis. Ceramide treatment increased glucose incorporation into FA progressively up to 24 h and at this time the increase was about 4.5-fold. Insulin stimulated glucose incorporation into the glycerol moiety of TAG by about 6-fold ( Figure 4B ). Preincubation with C 2 -ceramide for 2 h decreased the insulin-dependent incorporation by about 67% and after the 24 h preincubation there was no significant insulin-dependent incorporation. At this time total glucose incorporation into glyceride -glycerol was higher than in cells that were not exposed to C 2 -ceramide because C 2 -ceramide caused a 12-fold increase in glyceride -glycerol. It was predicted that increases in GLUT1 concentrations and glucose uptake after ceramide treatment would be a major contributor to the ceramide-induced in incorporation of glucose into TAGs. We therefore determined the effects of Figure 3 Activation of MAP kinase (ERK) by C 2 -ceramide and insulin. 3T3-L1 adipocytes were treated with 100 mM C 2 -ceramide for 2 or 12 h, and then exposed to 100 nM insulin for 5 min. The gel shift assays for MAP kinase were performed by Western blotting with a combination of ERK1 and ERK2 antibodies. Results are from a representative experiment that was repeated three times and ERK activities are given in Table 1 . 
Discussion
C 2 -and C 6 -ceramides were used for these studies since they are cell-permeable and C 2 -ceramide, in particular, is deacylated relatively slowly compared with long-chain ceramides. 23 Therefore, the effects of short-chain ceramides are mainly direct rather than involving metabolism to sphingosine or sphingosine 1-phosphate. 23, 24 TNFa and ceramides stimulate PI 3-K in 3T3 L1 adipocytes, 22, 25 fibroblasts, 23, 24 smooth muscle cells, 26 osteoclasts 45 and macrophages. 46 These increases in PI 3-K are associated with protection from apoptosis and increased division rather than cell death. The ceramide concentrations used in the present work were established from previous studies.
22
C 2 -ceramide severely inhibited the insulin stimulation of glucose incorporation into the glycerol and particularly the FA moieties of TAG. This effect parallels the inhibition of insulin-stimulated glucose uptake; it occurs after a 2 h preincubation with C 2 -ceramide and it is maintained for 24 h. C 6 -ceramide did not change the ED 50 of insulin for glucose uptake (Figure 1 ) and C 2 -ceramide did not decrease the tyrosine phosphorylation of the insulin receptor. The ceramide effect appeared to be downstream of PI 3-K. 22 The inhibitory effects of ceramides on TAG synthesis are, therefore, likely to reflect glucose availability, but there are additional actions on the relative partitioning of glucose into FA and glyceride/glycerol.
The second effect of ceramides is to increase the basal glucose uptake in the absence of insulin through a 5-fold increase in GLUT1 availability and a 9-fold increase at the plasma membrane. TNFa, 10 ng/ml, produced similar increases in GLUT1 concentration in this system after 24 h (our unpublished work), as expected. 29, 30 These effects of TNFa and ceramides resemble those reported for the longterm insulin action on GLUT1 which in 3T3-L1 adipocytes depend upon activation Ras, ERK and pp70 S6K . 44 We demonstrated previously that ceramides increase total and IRS-1-associated PI 3-K activity. 22 We now show that ceramides activate pp70 S6K , p65PAK and PKB which are downstream of PI 3-K. This explains the long-term insulin mimetic effects of ceramides. 22 We did not investigate the mechanism for these effects, but it may be significant that these kinases are activated by small G-proteins: Ras 47 and Rho 48 for PI 3-K and Cdc42 and Rac for pp70 S6K 44 and p65PAK. 36, 50, 51 Our work with Rat2 fibroblasts demonstrated that TNFa, sphingomyelinase and C 2 -ceramide increase Ras-GTP concentrations, the binding of Ras to activated PI 3-K 23 cause the subsequent activation Rac, Cdc42 and the physical interaction of Cdc42 with activated PAK. 24 The involvement of PI 3-K, pp70 S6K and ERK in increasing GLUT1 concentrations is confirmed by the partial inhibition of the ceramide effect by Ly 294002, rapamycin and PD 98059, which inhibit PI 3-K activity and the activations of pp70 S6K and ERK, respectively. Ly294002 could also have inhibited the mammalian target of rapamycin (mTOR). 52 The effects of the three inhibitors in decreasing GLUT1 expression were also reflected in the decreased stimulation of glucose uptake 22 and FA synthesis by C 2 -ceramide ( Figure 5A ).
Constitutively activated PKB stimulates glucose uptake in 3T3-L1 adipocytes and L6 myotubules in the absence of insulin partly through GLUT4 translocation to plasma membranes. 53, 54 Stimulation PKB activity by ceramides ( Ceramides and insulin signalling J Mei et al could therefore contribute to the ceramide-induced increase in GLUT1 and GLUT4 concentrations in plasma membranes observed in the absence of insulin. 22 Work in other cell types has also demonstrated TNFa and ceramides can activate PKB downstrem of PI 3-K. 45, 46, 55 However, ceramides can also prevent the translocation of proteins that bind 3-phosphoinositides despite their provision by PI 3-K. 56 The lack of PKB recruitment to plasma membranes in ceramide treated cells may explain the inhibition of insulin-stimulated glucose uptake. 27 It was reported that treatment of 3T2-L1 adipocytes with C 2 -ceramide lowered PKB activity in the presence of insulin. 28 In this work, C 2 -ceramide alone doubled basal glucose uptake as predicted from our previous 22 and present work. The ceramide inhibition of PKB activation by insulin is also compatible with our own results. The ceramide effects on PKB appear to be cell-type-specific. Activation of PKB by TNFa prevents apoptosis in osteoclasts 45 and in fibroblasts TNFa and ceramides can increase cell division rather than leading to cell death. 23 In HMN1 cells C 2 -ceramide decreases PKB activity after 15 min and induces apoptosis. 57 Different cell types also show large variations in the time of response. The increase in PKB activity was observed 2 and 24 h after C 2 -ceramide treatment ( Table 1 ). The effects of TNFa in decreasing the tyrosine phosphorylation of IRS-1 took 2 -4 days to occur in adipocytes, 9 whereas there was a decrease in the tyrosine phosphorylation of IRS-1 and its association with PI 3-K after 1 h in rat hepatoma Fao cells.
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Increased tyrosine phosphorylation of IRS-1 and binding to PI 3-K occurred after 20 -60 min in 3T3-L1 adipocytes. 25 In Rat2 fibroblasts, TNFa, sphingomyelinase and C 2 -ceramide increased PI 3-K transiently after 10 -20 min, 23, 24 whereas longer incubation times were required in 3T3-L1 adipocytes. 22 Furthermore, in Rat2 fibroblasts the stimulation of ERK was inhibited almost completely by Ly 294002, indicating the involvement of PI 3-K.
23 PI 3-K is thought to be particularly important for ERK activation in cells that do not exhibit large stimulations in response to growth factors. 47 In the present experiments activation of ERK by C 2 -ceramide was not inhibited by Ly 294002 and it may rely on increase in Ras-GTP 23 which can then stimulate Raf and MEK. Glucose incorporation into glyceride -glycerol is less dependent on insulin than that into FA (Figure 4) . Furthermore, incubation for 24 h with C 2 -ceramide stimulated the incorporation of glucose into glyceride -glycerol 12-fold compared with a 4.5-fold stimulation into FA. Ly294002, rapamycin or PD 98059 did not block the ceramide-induced increase in glyceride -glycerol synthesis ( Figure 5B), although glucose uptake was decreased by these inhibitors. 22 The present results demonstrate that ceramides produced a rapid and sustained insulin resistance in both glucose uptake and TAG synthesis. However, ceramides stimulate insulinindependent glucose uptake and incorporation into FA and particularly glyceride -glycerol. This is despite the effects of ceramides 58 and TNFa 59 in increasing cAMP concentrations in 3T3 L1 adipocytes due to a time-dependent decrease in phosphodiesterase 3B activity resulting in increased lipolysis.
A ceramide-induced increase in cAMP and FA concentrations should produce a substantial decrease in FA synthesis, whereas the increased FA availability should increase TAG synthesis from glycerol phosphate. Assuming that 1 mol of glucose could provide 2 mol of glyceride -glycerol or acetate for FA biosynthesis, the provision of carbon atoms from glucose alone cannot sustain TAG synthesis. This applies especially after long-term incubation with C 2 -ceramide where total FA synthesis is decreased by about 75% compared to the control in the presence of insulin and where glyceride -glycerol production is increased. C 2 -ceramide increased total lipolysis after 24 h in our experimental system by 1.8 -3.1-fold. 58 This could contribute to the 12-fold increase in glyceride -glycerol production (Figure 4) , but the 7.5-fold increased in glucose uptake 22 and the 4.5-fold increase in FA synthesis are also important.
The ceramide-induced changes in TAG synthesis that we observed in cell culture are likely to occur in vivo. For example, preferential incorporation of glucose into glycerideglycerol rather than FA was observed with insulin resistant adipose tissue from JCR:LA rats. 33 In normal Wistar rats FA synthesis predominates. 32 Insulin resistance is commonly associated with increased circulating FA and hypertriglyceridaemia 2 and therefore adipose tissue is able to acquire FA from the circulation in this condition. The observations that TNFa increased GLUT1 concentrations and basal glucose uptake 22, 29, 30, 62 are also compatible with TNFa stimulating the peripheral glucose uptake in vivo. 63 Furthermore, GLUT1 expression in plasma membranes from skeletal muscle of obese diabetic SHR rats is increased by 40% compared to the lean genotype. 64 The idea that ceramides are responsible for part of the TNFa signalling pathway in exacerbating insulin resistance may seem paradoxical if, on their own, ceramides stimulate insulin-independent glucose uptake and TAG synthesis in the long term. However, despite an increase in non-insulin-stimulated (basal) glucose uptake, insulinresistant tissue is unable to respond with sufficient glucose uptake to dispose of a post-prandial glucose load effectively.
Our work provides further mechanisms for the effects of TNFa and ceramides in decreasing the importance of insulin as a regulator of metabolic balance in adipose tissue. The results also provide insight into the association between obesity and insulin resistance. TNFa and ceramides decrease the effects of insulin in stimulating glucose uptake and TAG synthesis. However, they increase the capacity to store glucose in TAG, especially in the glycerol moiety, in the face of insulin resistance. At the same time lipolysis is increased by TNFa and ceramides. This increased turnover of FA, especially from the increased adipose tissue mass in android obesity, aggravates insulin resistance and the progression of the Metabolic Syndrome. 
